STOCKWATCH
·
QMeter

Meter

Quarterly Results Intelligence

AUROBINDO PHARMA LTD.03 Apr 2026
Q3

AUROBINDO PHARMA LTD.

AUROPHARMAFY2603 Apr 2026
Sentiment:Bullish
Short-term:Optimistic
Long-term:Very Optimistic
Market:Neutral
Revenue
Net Profit
OPM

Management Guidance

Aurobindo Pharma targets an EBITDA margin on the higher side of 20% to 21% for FY26, projecting sustained growth across its business segments. The European business is expected to exceed 1 billion Euro in annual revenue by FY26, while the Pen-G facility, benefiting from the new Minimum Import Price, is set to significantly uplift profitability from Q1 FY27, with annual production over 10,000 MT. Strategic initiatives, including the Lannett acquisition (expected Q1 FY27), and ramp-up of new facilities (Dayton, China OSD, Vizag Injectables) are anticipated to drive substantial revenue and EBITDA contributions from FY27-FY28. The company is also progressing its biosimilar strategy, with 2029 marked as an inflection year for that business, supported by continuous R&D investment and a robust product pipeline.

P/L Statement (in crores)

Press Releases

SRI ADHIKARI BROTHERS TELEVISION NETWORK LTD.

Aqylon Nexus Q4/FY26 Results, UAE Subsidiary, Director Resigns

Aqylon Nexus Limited reported financial updates for Quarter and year ended March 31, 2026.

yesterday
TATA CONSULTANCY SERVICES LTD.

TCS Closes FY26 with Improving Sequential Growth Momentum, Strong Deal Wins, and Highest Operating Margin in Last 4 Years

K

K Krithivasan

We are pleased to report the third consecutive quarter of sequential growth, supported by three mega deals and a $12 billion TCV, underscoring the strength of our five pillar strategy and our AI led positioning across services. It is equally encouraging that this momentum was broad based across major markets and most industries. While the macro-economic headwinds continue, we see sustained customer conviction in technology investments, which positions us well for the opportunities ahead.”

3d ago
Anand Rathi Wealth Ltd

Anand Rathi Wealth Ltd Announces 28% Y-o-Y PAT Growth, 1:1 Bonus Issue, and Final Dividend of ₹ 7 per Share for FY26

R

Rakesh Rawal

We continued to deliver another quarter of consistent, market- agnostic performance, driven by our uncomplicated approach and unwavering focus on our clients’ financial well-being. The mean of year-on-year growth of our last 16 quarters profit has been 32.2%, with a median of 33.2% and a standard deviation of 4.5%, reflecting the consistency of our performance. Amid a sharp correction in equity markets, which also created opportunities for disciplined investing, we stayed focused on our approach. For this, we remain grateful to our clients for their continuous support and to our team members for their commitment and hard work.

4d ago
Gaudium IVF and Women Health Ltd

Gaudium IVF Announces Q3 & 9M FY26 Financial Results, Raises ₹1,650.098 Crore in IPO

D

Dr. Manika Khanna

This is not just a quarter of strong performance, it reflects a category that is coming of age, and Gaudium IVF is at the forefront of shaping it. Our listing marks a structural shift, from building a trusted clinical brand to institutionalising a scalable, future-ready healthcare platform. We have been deliberate in how ygaudium IVF we grow, combining clinical excellence with operational discipline. The opportunity in fertility care in India is significantly underpenetrated, and we see ourselves not just participating in this growth but leading it. Our focus is clear, expand access, deepen outcomes, and build India’s most trusted and outcome-driven fertility network.

19 Mar
PANYAM CEMENTS & MINERAL INDUSTRIES LTD.

Panyam Cements & Mineral Industries Ltd. Approves Q3 Financial Results for FY2026

D

Dr. Srinisha Jagathrakshakan

The above un-audited results were reviewed by Audit committee and approved by the Board of Directors at their Meetings held on 14th Februa

14 Mar
Shree Securities Ltd

Shree Securities Ltd. Approves Unaudited Financial Results for Q1, Q2, and Q3 of FY 2025-2026

B

Bhavya Dhiman

By order of the Board For SHREE SECURITIES LIMITED

10 Mar
KWIL

Kwality Walls (India) Ltd Reports Q3FY26 Results: Organic Sales Growth -6.5%, Volume Growth 1.2%

C

Chitrank Goel

This quarter marks an important milestone for our Company as we commence external reporting following the completion of the demerger. The period under review has been both transformative and challenging. This marks the start of a new chapter, with a clear focus on delivering superior experiences for our consumers, creating opportunities for our people, and driving long-term shareholder value. The ice cream category in India is at an attractive inflection point, with low levels of per capita consumption, headroom for cabinet penetration, improved refrigerator penetration at homes, and unlocking of new snacking consumption occasions enabled by the rise of quick commerce—providing a strong foundation for sustained volume growth. Q3 FY26 growth was muted due to prolonged monsoon conditions and GST transition-related impacts. In this context, our power brands, Magnum and Cornetto, delivered strong volume growth, underscoring the resilience of our portfolio and continued consumer demand. Performance of the in-home portfolio was muted, and corrective actions are underway. We have initiated structural cost control measures aimed at restoring margin discipline without compromising growth investments. We have laid the foundation for a focused lce-Cream Company with sharper strategic intent and greater agility to deliver sustainable and profitable growth. | would like to thank our employees, customers, partners, and shareholders for their continued support during this transformative phase.”

7 Mar
DCM Shriram International Ltd

DCM Shriram International Ltd Announces Q3 Results for FY2025-26

rev: 11,844

6 Mar
AYE

Aye Finance Announces Strong Q3 FY26 Results: FY26 Outperforms FY25 with 87% PAT Growth and 23.5% AUM Surge

S

Sanjay Sharma

Our Q3 results demonstrate the resilience of the micro-enterprise sector and our ability to bridge the credit gap for underserved businesses. Disbursals are accelerating, and we remain firmly on track to deliver the 29-30% AUM growth in FY26 and beyond. With asset quality improved to normalised levels, we have cleared the runway for a sharp, sustained uptickin profitability over the coming quarters. Our focus remains on sustaining this trajectory through disciplined underwriting and a customer-centric approach enabled by technology & data science

6 Mar
FRACTAL

Fractal Analytics Crosses Rs 100 Cr PAT in Q3, Revenue Grows 21% YoY

S

Srikanth Velamakanni

We delivered a great quarter, improving across nearly every metric. Our best-in-class organic growth, gross margins, and high client retention reflect the strength of our enterprise Al capabilities and the trust our clients place in us. We have built a disciplined, high-performance organization focused on solving complex enterprise problems with Al. As adoption scales across industries, Fractal is well positioned to lead this transformation while creating sustained long-term value for our clients and shareholders.”

5 Mar

Earnings Call Recordings

Management Sentiment

Positive Outlook

Aurobindo Pharma Reports Robust Q3 FY26, Strategic Initiatives Drive Confident Outlook

AUROBINDO PHARMA LTD. · AUROPHARMA

Sentiment: BullishShort Term: OptimisticLong Term: Very OptimisticTone: ConfidentRisk: Medium

Management Guidance

Aurobindo Pharma targets an EBITDA margin on the higher side of 20% to 21% for FY26, projecting sustained growth across its business segments. The European business is expected to exceed 1 billion Euro in annual revenue by FY26, while the Pen-G facility, benefiting from the new Minimum Import Price, is set to significantly uplift profitability from Q1 FY27, with annual production over 10,000 MT. Strategic initiatives, including the Lannett acquisition (expected Q1 FY27), and ramp-up of new facilities (Dayton, China OSD, Vizag Injectables) are anticipated to drive substantial revenue and EBITDA contributions from FY27-FY28. The company is also progressing its biosimilar strategy, with 2029 marked as an inflection year for that business, supported by continuous R&D investment and a robust product pipeline.

3 Apr

Physicswallah Reports Robust Q3 FY26 Growth, Strategic Expansion in K-12 & AI, Strong Outlook

Physicswallah Ltd · PWL

Sentiment: BullishShort Term: OptimisticLong Term: Very OptimisticTone: ConfidentRisk: Medium

Management Guidance

Physicswallah projects a full-year revenue growth in the range of 32% to 35% for FY26, with anticipated full-year marketing expenditures to be significantly lower at 8%-8.5% of revenue. The company plans to allocate INR400 crores for K-12 platform investments and INR200 crores for 70 new offline centers next year, focusing on increasing online revenue share and expanding new online categories. Management also expects to announce further M&As within India in the next two quarters, targeting profitable entities with group synergies.

3 Apr

Ashiana Housing Q3 FY26: Exceeds Presales Target, Strong Senior Living Momentum, Targets 20% ROE

ASHIANA HOUSING LTD.-$ · ASHIANA

Sentiment: BullishShort Term: OptimisticLong Term: Very OptimisticTone: ConfidentRisk: Medium

Management Guidance

Ashiana Housing surpassed its FY26 presales target of INR2,000 crores and anticipates similar presales for the next fiscal year. The company is strategically pivoting towards senior living, expecting this segment to grow at a 25-30% CAGR, enhancing overall margins and business stability. Management is confident in achieving a 20% Return on Equity (ROE) by the next financial year and maintaining the INR11,000 crores cumulative sales/delivery target by FY30. Key land acquisitions in Bangalore and Panvel are expected to close in the next 3-6 months to bolster the future launch pipeline.

3 Apr

Ashiana Housing Q3 FY26: Exceeds Presales Target, Strong Senior Living Momentum, Targets 20% ROE

ASHIANA HOUSING LTD.-$ · ASHIANA

Sentiment: BullishShort Term: OptimisticLong Term: Very OptimisticTone: ConfidentRisk: Medium

Management Guidance

Ashiana Housing surpassed its FY26 presales target of INR2,000 crores and anticipates similar presales for the next fiscal year. The company is strategically pivoting towards senior living, expecting this segment to grow at a 25-30% CAGR, enhancing overall margins and business stability. Management is confident in achieving a 20% Return on Equity (ROE) by the next financial year and maintaining the INR11,000 crores cumulative sales/delivery target by FY30. Key land acquisitions in Bangalore and Panvel are expected to close in the next 3-6 months to bolster the future launch pipeline.

3 Apr

CCL Products Delivers Strong Q3 FY26, Upgrades EBITDA Outlook, Driven by Volume Growth & Deleveraging

CCL PRODUCTS (INDIA) LTD. · CCL

Sentiment: BullishShort Term: OptimisticLong Term: Very OptimisticTone: ConfidentRisk: Low

Management Guidance

Management reported strong Q3 and 9M FY26 performance with turnover growth of 38% and 42% respectively, expecting consistent volume growth of 18-20% for the full year. FY26 EBITDA growth guidance has been revised upwards to approximately 25% from the earlier 15-20%. The company is ahead of its debt reduction guidance, achieving net debt of ~INR1248 crores as of December 2025 against a target of INR1250 crores by March 2026, driven by working capital efficiencies. Long-term, CCL Products aims for 85-90% capacity utilization within two years and plans to maintain stable EBITDA per kilogram through its cost-plus model, while aggressively growing its India branded business to an estimated INR430-440 crores for FY26 and continuously exploring product innovation and market diversification.

3 Apr

J&K Bank Reports Strong Q3 FY26 Results with Asset Quality Improvement, Robust Credit Growth & Optimistic Outlook

JAMMU & KASHMIR BANK LTD. · J&KBANK

Sentiment: BullishShort Term: OptimisticLong Term: OptimisticTone: ConfidentRisk: Medium

Management Guidance

Management reaffirmed FY26 guidance for credit growth at 12-15%, deposit growth at 10%, and net interest margin (NIM) at 3.65-3.7%, with Gross NPA expected to remain below 3% (already achieved). Return on Assets (ROA) is guided at 1.2-1.25% and Return on Equity (ROE) at 15-16%. The bank plans to raise equity capital up to INR750 crores and Tier 2 capital up to INR500 crores to support projected business growth over the next two years, aiming to increase the Credit-to-Deposit (CD) ratio to 76-78%. While the CASA guidance has been revised due to evolving customer preferences, NIM is expected to improve in Q4 FY26 as deposit repricing fully kicks in, and employee costs are projected to continue declining in FY27 due to retirements.

3 Apr

IMFA Posts Strong Q3, Advances Major Capacity Expansion and Integrated Growth Strategy

INDIAN METALS & FERRO ALLOYS LTD. · IMFA

Sentiment: BullishShort Term: OptimisticLong Term: Very OptimisticTone: ConfidentRisk: Medium

Management Guidance

Management projects Q4 FY'26 realizations and EBITDA margins to be similar to Q3, with a slight upward bias. Key expansions include the Kalinganagar greenfield project (KNR 1) with first furnace commissioning in June 2026, and the Kalinganagar acquisition (KNR 2) expected to close in Q4 FY'26 with volumes contributing from Q1 FY'27. The ethanol project is set for commissioning in March 2026, contributing from FY'27. Ferrochrome production volume is targeted at approximately 400,000 tonnes in FY'27 and 475,000 to 500,000 tonnes in FY'28. Ore raising is guided to 850,000 tonnes in FY'26 and 1 million tonnes in FY'27, fully catering to increased captive demand. Total capex for the next two years is projected around INR1,000 crores, and the company maintains a conservative debt outlook, expecting debt-to-equity not to exceed 0.3.

3 Apr

Triveni Turbine Achieves Record Q3, Confident in FY26 Growth & Strong Long-Term Outlook Driven by New Markets & Products

TRIVENI TURBINE LTD. · TRITURBINE

Sentiment: BullishShort Term: OptimisticLong Term: Very OptimisticTone: ConfidentRisk: Medium

Management Guidance

For FY26, management expects double-digit top-line growth, with Q4 projected to be a record quarter for turnover, profitability, and order booking, recovering from prior deferrals. EBITDA margins are anticipated to remain above 20% on a PBT basis, despite fluctuations and contributions from lower-margin projects like NTPC. For FY27, growth is expected to be commensurate with or slightly higher than FY26, with the U.S. subsidiary targeted to break-even and MVR/heat pump orders commissioned. Long-term, from FY28 onwards, the company anticipates a return to normalized growth rates, driven by expanding export markets (including significant contributions from the U.S.), new application areas such as geothermal and energy storage, and continued R&D for product development and platform changes.

3 Apr

PB Fintech: Accelerating Protection Growth, Expanding Profitability & Strategic International Vision

PB Fintech Ltd · POLICYBZR

Sentiment: BullishShort Term: OptimisticLong Term: Very OptimisticTone: ConfidentRisk: Medium

Management Guidance

Management expects all new initiatives to achieve break-even or profitability from this point forward, reinforcing overall company earnings. While immediate quantitative guidance was not provided, the company anticipates sustained strong growth in its core insurance business, driven by enhanced customer trust and efficient operations. Strategically, PB Fintech plans to pursue international expansion, pending board and shareholder approvals, and will continue to diversify Paisabazaar's offerings into a full financial platform including bonds and mutual funds. Capital deployment for acquisitions is expected to be EPS or PE accretive, focusing on transforming and enhancing competitive positioning in target markets.

3 Apr

Aurobindo Pharma Q3 FY26: Strong Growth, Positive Catalysts & Strategic Expansion

AUROBINDO PHARMA LTD. · AUROPHARMA

Sentiment: BullishShort Term: OptimisticLong Term: Very OptimisticTone: ConfidentRisk: Medium

Management Guidance

Aurobindo Pharma expects to achieve consolidated EBITDA margins on the higher side of 20-21% for FY26, driven by sustained growth in Europe (projected to exceed 1 billion Euro annual revenue) and improved performance in US injectables. Key strategic initiatives, including the ramp-up of the Pen-G facility with expected profitability uplift from Q1 FY27 due to MIP, EBITDA break-even for OSD China in Q4 FY26, and significant revenue contributions from the Dayton facility and Vizag injectables from FY27-28, are set to fuel future growth. The Lannett acquisition is anticipated to close in Q1 FY27, further strengthening the US business, while the biosimilars strategy aims for an inflection point by 2029 through ongoing filings and commercialization.

3 Apr

Cautious Outlook

E.I.D. Parry Q3 FY26: Mixed Results Amid CPG Restructuring & Sugar Headwinds; Strategic CPG Expansion Planned

E.I.D.-PARRY (INDIA) LTD. · EIDPARRY

Sentiment: NeutralShort Term: Cautiously OptimisticLong Term: OptimisticTone: ConfidentRisk: Medium

Management Guidance

Management expects the Consumer Products Group (CPG) channel correction to conclude in Q4 FY26, anticipating a stronger operating model and improved performance in Q1 FY27, with plans to announce new food FMCG categories and explore inorganic growth opportunities. For the sugar and biofuel segments, the focus remains on operational efficiency and cost management, though significant improvement is largely dependent on favorable policy revisions for Minimum Support Price (MSP) and ethanol pricing. The refinery business aims to sustain its reduced cost levels but forecasts continued pressure on white premium for the next two quarters.

3 Apr

Shalby Q3 FY26: Hospital Headwinds Addressable, MedTech Turns Positive, Strategic Investments Drive Future Growth

Shalby Ltd · SHALBY

Sentiment: NeutralShort Term: Cautiously OptimisticLong Term: OptimisticTone: ConfidentRisk: Medium

Management Guidance

Management expects double-digit volume growth and 5-6% ARPOB growth for the hospital business, driven by strategic investments in robotics, diagnostics, and clinical talent. Shalby MedTech is projected to continue its high growth trajectory (40-60%) with operating leverage and has achieved EBITDA positivity, aiming for future PAT breakeven. Overall group EBITDA margins are targeted to stabilize at 20% for typical units and could reach 23-25% at higher occupancy levels. The company anticipates a significant ramp-up in Shalby International (PK Healthcare) within 1-2 quarters post NABH approval and projects net debt to decrease over the next 12 months with no significant capex planned for the hospital business during this period.

3 Apr

Best Agrolife Q3 FY26: Weather Challenges & Strategic Shift Towards Patented Products for Growth

Best Agrolife Ltd · BESTAGRO

Sentiment: NeutralShort Term: Cautiously OptimisticLong Term: OptimisticTone: ConfidentRisk: High

Management Guidance

Management expects FY26 revenue to be between Rs. 1,300-1,400 crores with an EBITDA margin of around 12%. For Q4 FY26, the focus is on achieving break-even or a small profit, avoiding losses. Looking ahead, FY27 revenue is projected to grow to Rs. 1,500-1,600 crores, aiming to surpass Rs. 1,700-1,800 crores within the next two years, with operating profit margins expected to reach a minimum of 16-17%, potentially 20%. The strategic direction emphasizes a continued shift towards high-margin patented products, expansion in international markets, and enhanced operational efficiency through data analytics and AI, while CAPEX remains on hold for now.

3 Apr

Nucleus Software: Steady Revenue Growth, Profit Dip; Strategic Focus on AI & FinnOne Neo for Future

NUCLEUS SOFTWARE EXPORTS LTD. · NUCLEUS

Sentiment: NeutralShort Term: Cautiously OptimisticLong Term: OptimisticTone: ConfidentRisk: Medium

Management Guidance

Management did not provide specific revenue or earnings guidance. However, they anticipate a significant sales pipeline to convert in upcoming quarters, driven by strengthened sales leadership. The cost of delivery is expected to see an uptick due to new labor code changes, though the company plans initiatives to contain these costs, including potential long-term benefits from AI adoption. Strategic direction focuses on the ongoing, multi-year migration of customers to the FinnOne Neo platform, embedding AI capabilities across existing product offerings, and expanding partnerships, particularly with fintechs. Growth is targeted in the MSME, gold loan, finance against securities, and co-lending segments, with a core focus on improving customer NPS.

3 Apr

HCC Q3 FY26: Strong Margins & Deleveraging Fuel Optimistic Growth Outlook & Nuclear Ambitions

HINDUSTAN CONSTRUCTION CO.LTD. · HCC

Sentiment: BullishShort Term: Cautiously OptimisticLong Term: Very OptimisticTone: ConfidentRisk: Medium

Management Guidance

Management aims for 20-25% annual revenue growth and doubling turnover every three years, with a commitment to make up for any current year's order intake shortfall in the coming months. The company expects to maintain strong EBITDA margins (over 15%) and aims to become debt-free within the next two to three years after successfully meeting its FY26 debt reduction target. Strategic direction is focused on complex infrastructure projects in India, particularly nuclear power, urban transport, and hydro, anticipating substantial orders from early 2028, complemented by opportunistic international expansion.

3 Apr

Bharti Airtel Q3 FY26: Strong Performance, ARPU Growth, Strategic DC/AI Investments Drive Future Outlook

BHARTI AIRTEL LTD. · BHARTIARTL

Sentiment: BullishShort Term: Cautiously OptimisticLong Term: OptimisticTone: ConfidentRisk: Medium

Management Guidance

Management expects continued ARPU-led growth driven by portfolio premiumization, feature phone to smartphone upgrades, prepaid to postpaid migrations, data monetization, and international roaming, in the absence of explicit tariff repair. Significant investments are planned for Data Centers, aiming for 1 gigawatt capacity in 3-4 years, alongside continued capital allocation to fiber rollout and transport network modernization, with some moderation in radio 5G capex as device adoption grows. The company will maintain its focus on operational excellence and 'war on waste' initiatives to sustain margin improvement, while leveraging digital acceleration and AI for revenue growth, product differentiation, and cost efficiency. The balance sheet will be strategically deployed for organic growth and potential inorganic opportunities in fragmented markets like Data Centers and B2B, with a progressive dividend policy.

3 Apr

EID Parry Q3 FY26: CPG Strategic Pivot, Sugar/Biofuel Challenges Amid Global Surplus & Policy Needs

E.I.D.-PARRY (INDIA) LTD. · EIDPARRY

Sentiment: NeutralShort Term: Cautiously OptimisticLong Term: OptimisticTone: ConfidentRisk: Medium

Management Guidance

Management expects Q4 sugar operations to show improved profitability due to seasonal factors. The Consumer Product Group's channel correction is anticipated to conclude in Q4 FY26, with a return to a more efficient operating model and better growth clip in Q1 FY27. New food FMCG categories beyond staples and sweeteners are slated for announcement in the May call (Q1 FY27), with an openness to inorganic growth. Distillery faces continued ethanol pricing pressure for approximately another month. The refinery business expects lower white premium environment to persist for at least the next two quarters, though cost levels are deemed sustainable. Overall, the company will focus on operational efficiency and awaits policy support for sugar and ethanol prices.

3 Apr

Divi's Labs Q3FY26: Robust CS & Peptide Pipeline, Unit 3 Progress & FY27 Commercialization Outlook

DIVI'S LABORATORIES LTD. · DIVISLAB

Sentiment: BullishShort Term: Cautiously OptimisticLong Term: OptimisticTone: ConfidentRisk: Medium

Management Guidance

Management expects sustained growth, aiming for a double-digit constant currency trajectory, driven by the commercialization of dedicated Custom Synthesis projects by Q3/Q4 2027 and continued momentum in Nutraceuticals and the peptide segment. Margin improvement is anticipated through favorable product mix towards Custom Synthesis and efficiency gains from Unit 3's backward integration. The company has a significant capex plan of ₹1900 crores for FY26, with further capacity expansion (Kakinada Phase 2) under evaluation, reinforcing strategic focus on high-growth segments and operational excellence.

3 Apr

PTC India: Strong Volume Growth & Strategic Synergies Offset Lower Rebate; Optimistic on Future Power Market Evolution

PTC INDIA LTD. · PTC

Sentiment: NeutralShort Term: Cautiously OptimisticLong Term: OptimisticTone: ConfidentRisk: Medium

Management Guidance

Management anticipates power demand to remain firm, despite acknowledging potential short-term volatility. While Q3 and 9M FY26 financial results show a decrease in operational income and profit primarily due to lower net rebate and surcharge income (attributed to improved DISCOM liquidity), the company emphasizes robust growth in trading volumes as a key performance indicator. PTC expects positive indirect benefits for its associate HPX from market coupling once regulatory frameworks are established. Strategically, the company is actively exploring new investment avenues and partnerships through MoUs with PSUs like Neyveli Lignite and SECI, leveraging its strong cash reserves beyond working capital requirements. The impending change in promoter structure, with NTPC becoming the sole promoter, is expected to create significant synergistic opportunities by channeling NTPC's surplus power through PTC's trading platform. The divestment process for PFS is ongoing, with management prioritizing value creation.

3 Apr

TCPL Packaging Q3FY26: Strong Domestic Growth & Margin Expansion Offset Export Weakness; Strategic Initiatives Position for Future

TCPL PACKAGING LTD.-$ · TCPLPACK

Sentiment: BullishShort Term: Cautiously OptimisticLong Term: OptimisticTone: ConfidentRisk: Medium

Management Guidance

Management anticipates healthy domestic demand to be the primary growth driver, supported by government policies and expected to continue double-digit growth. While export markets remain subdued, recent trade agreements with the US and EU are expected to gradually improve sentiment and create a more favorable operating environment over time, though full benefits will take time to materialize. The company is strategically focused on capturing growth through industry consolidation, backward integration with new facilities like the gravure cylinder plant, and expects improved utilization at the Chennai plant in the near term. Annual capital expenditure is projected to be around INR 100 crore for FY27, aiming for a 1.5x turnover generation per rupee invested.

3 Apr